흰쥐에서 인도메타신으로 유발된 위염에 대한 까마귀쪽나무열매추출물의 보호효과
Protective effect of Litsea japonica fruit flesh extract on indomethacin-induced gastritis in rats
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The objective of this study was to investigate the inhibitory effects of Litsea japonica fruit flesh extract (LJF-HE) on gastritis in an indomethacin-induced SD rat model. Rats were randomly divided into six groups: G1 (normal group), G2 (control group, indomethacin-induced gastritis), G3 (positive group, indomethacin-induced gastritis and ranitidine 50 mg/kg), G4 (LJF-HE-L group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 30 mg/kg), G5 (LJF-HE-M group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 60 mg/kg), G6 (LJF-HE-H group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 120 mg/kg). In the group treated with LJF-HE (G4, G5, and G6), gastric mucosal damage, gastric juice secretion and pepsin activity were significantly decreased compared to the control group. Additionally, there were decreases in the expression of cholecystokinin 2 receptor (CCK-2r), histamine receptor H2 (H2r) and H+/K+ ATPase in the gastric lesions. The plasma levels of TNF-α and IL-1β significantly decreased in LJF-HE (G4, G5, and G6) treated groups compared with control. The plasma level of PGE2 was also significantly increased by LJF-HE (G5 and G6). These results suggest that LJF-HE (G4, G5, and G6) has the ability to inhibit on indomethacin-induced gastritis.
Abstract
The objective of this study was to investigate the inhibitory effects of Litsea japonica fruit flesh extract (LJF-HE) on gastritis in an indomethacin-induced SD rat model. Rats were randomly divided into six groups: G1 (normal group), G2 (control group, indomethacin-induced gastritis), G3 (positive group, indomethacin-induced gastritis and ranitidine 50 mg/kg), G4 (LJF-HE-L group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 30 mg/kg), G5 (LJF-HE-M group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 60 mg/kg), G6 (LJF-HE-H group, indomethacin-induced gastritis and L. japonica fruit flesh extract at 120 mg/kg). In the group treated with LJF-HE (G4, G5, and G6), gastric mucosal damage, gastric juice secretion and pepsin activity were significantly decreased compared to the control group. Additionally, there were decreases in the expression of cholecystokinin 2 receptor (CCK-2r), histamine receptor H2 (H2r) and H+/K+ ATPase in the gastric lesions. The plasma levels of TNF-α and IL-1β significantly decreased in LJF-HE (G4, G5, and G6) treated groups compared with control. The plasma level of PGE2 was also significantly increased by LJF-HE (G5 and G6). These results suggest that LJF-HE (G4, G5, and G6) has the ability to inhibit on indomethacin-induced gastritis.
참고문헌 (35)
- Glickman JN, "Gastritis", Gastrointest Endosc Clin North Am, 11, pp.717~740 (2001)
- Aro P, "Anxiety is associated with uninvestigated and functionalepsia(ROME III criteria)in a Swedish population based study", Gastroenterol, 137, pp.94~100 (2009)
- Srivastava A, "Pathology of non-infective gastritis", Histopathology, 50, pp.15~29 (2007)
- Franke A, "Alcohol-related diseases of the esophagus and stomach", Dig Dis, 23, pp.204~213 (2005)
- Dajani EZ, "Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man", J Physiol Pharmacol, 59(Suppl 2), pp.117~133 (2008)
- "Gastritis. Jackson Siegelbaum Gastroenterology" (2006)[URL]
- Fullarton GM, "Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist", Gut, 30, pp.449~454 (1989)
- Szabo S, "Alternatives to the acid-oriented approach to ulcer disease: does 'cytoprotection' exist in man? A new classification of antiulcer agents", Scand J Gastroenterol, 23, pp.1~6 (1988)
- Berardi RR, "Maintenance therapy for prevention of recurrent peptic ulcers", Drug Intell Clin Pharm, 21, pp.493~501 (1987)
- Raveendra KR, "An extract of Glycyrrhiza glabra (GutGard) alleviates symptoms of functional dyspepsia: a randomized, double-blind, placebo-controlled study", Evidence-Based Complemen-tary and Alternative Medicine, 2012, pp.216970~ (2012)
- Mukherjee M, "Anti-ulcer and antioxidant activity of GutGardTM", Indian J Exp Biol, 48, pp.269~274 (2010)
- Dabos KJ, "Is Chios mastic gum effective in the treatment of functional dyspepsia? A prospective randomised double-blind placebo controlled trial", J ethnopharmacology, 127, pp.205~209 (2010)
- 남다은, "위염 동물모델과 위 벽세포에서 히스타민 경로를 통한 매스틱검 (Chios Mastic Gum)의 위산 분비 억제효과 및 기전 연구", 한국식품영양과학회지, 43(10), pp.1500~1509 (2014), 한국식품영양과학회
- Fernandez-Travieso JC, "Effects of Abexol®(beeswax alcohols)in patients with gastric symptoms", Revista CENIC Ciencias Biológicas, 43, pp.9~16 (2012)
- Carbajal-Quintana D, "Effects of D-002, a mixture of beeswax alcohols, on the acetic acid-induced writhing test in mice: a comparison with naproxen, aspirin, and paracetamol", Revista CENIC Cienc Biol, 44 (2013)
- Holtmann G, "Efficacy of artichoke leaf extract in the treatment of patients with functional dyspepsia: a six‐week placebo‐controlled, double‐blind, multicentre trial", Aliment Pharmacol Ther, 18, pp.1099~1105 (2003)
- Min BS, "Lactones from the leaves of the Litsea japonica and their anti-complement activity", J Nat Prod, 66, pp.1388~1390 (2003)
- Kim SH, "Suppressive effect of the n-hexane extract of Litsea japonica fruit flesh on monosodium-iodoacetate-induced osteoarthritis in rats", Evidence-Based Complementary Altern Medi, pp.10~ (2017)
- Ahn YS, "Randomized double-blind placebo-controlled study of the efficacy of Litsea japonica fruit extract in subjects with mild to moderate knee osteoarthritis", J Funct Foods, 34, pp.304~310 (2017)
- Jeong YJ, "Anti-osteoarthritic effects of the Litsea japonica fruit in a rat model of osteoarthritis induced by monosodium iodoacetate", PLoS One, 10, pp.e0134856~ (2015)
- 윤원종, "까마귀쪽나무 열매 추출물의 골관절염 억제 효과", 한국자원식물학회지, 28(5), pp.591~599 (2015), 한국자원식물학회[DOI]
- JimEnez-PErez NDC, "Essential oils in Mexican bays (Litsea spp., Lauraceae): taxonomic assortment and ethnobotanical implications", Econ bot, 65, pp.178~189 (2011)
- Urushidani T, "Effects of various amino acids on indomethacin-induced gastric ulcers in rats", The Jpn J Pharmacol, 27, pp.316~319 (1977)
- 정춘식,현진이,강민희, "생약복잡체 P020701의 항위염 및 항궤양 효과", 생약학회지, 33(4), pp.389~394 (2002), 한국생약학회
- Kurebayashi Y, "Cytoprotective action of cetrexate against HCl-ethanol induced gastric lesion in rats", The Jpn J Pharmacol, 46, pp.17~25 (1988)
- Anson ML, "The estimation of pepsin, trypsin, papain, and cathepsin with hemoglobin", J gen physiol, 22, pp.79~89 (1938)
- 이명렬, "지유가 흰쥐의 급성위염 및 소화성 궤양에 미치는 영향", 한국식품영양과학회지, 34(10), pp.1545~1552 (2005), 한국식품영양과학회
- Korea Food and Drug Administration, "Guidance for evaluation on efficacy of health functional food (can help improve stomach health or digestion)", Korea Food and Drug Administration, ~ (2016)
- Okabe S, "Effects of 15(R)-15-methyl prostaglandin E2(arbaprostil)on gastric secretion and various gastric lesions induced in rats", Jpn J Pharmacol, 40, pp.329~337 (1986)
- Seijffers MJ, "Separation of pepsinogen I, pepsinogen II, and pepsinogen III from human gastric mucosa", Am J Physiol, 205, pp.1106~1112 (1963)
- Kim DB, "Functional testing guide of functional health food", Korea Health Supplement Association, 554~559 (2004)
- 김신정, "염산-에탄올에 의해 유발된 흰쥐 위염에 대한 생강 및 법제생강 추출물의 억제작용", 한국식품영양과학회지, 41(11), pp.1528~1533 (2012), 한국식품영양과학회
- Chen D, "Complexity of gastric acid secretion revealed by targeted gene disruption in mice", Curr Pharm Des, 16, pp.1235~1240 (2010)
- Schubert ML, "Gastric secretion", Curr Opin Gastroenterol, 23, pp.595~601 (2007)
- Osawa H, "Helicobacter pylori eradication induces marked increase in H+", K+ adenosine triphosphatase expression without altering parietal cell number in human gastric mucosa, 2006, pp.55, 152~157